Back to Newsroom

BackBeat Medical Clinical Data Presented at TCT 2016 Show Continued Reduction in Blood Pressure Over One Year with Cardiac Pacing-Based Hypertension Treatment

NEW HOPE, Pa., Oct. 31, 2016 /PRNewswire/ — BackBeat Medical Inc. today announced the presentation of data demonstrating a continued significant reduction in blood pressure over a one year period with the company’s patented Programmable Hypertension Control (PHC) therapy for the treatment of hypertension. The data were presented by the study’s principle investigator, Karl-Heinz Kuck, M.D., at the Transcatheter Cardiovascular Therapeutics (TCT) 2016 conference in Washington, DC.

Click here to read the full release